Modulation of melanoma cell phospholipid metabolism in response to heat shock protein 90 inhibition

Molecular chaperone heat shock protein 90 (Hsp90) inhibitors are promising targeted cancer therapeutic drugs, with the advantage that they deplete multiple oncogenic client proteins and modulate all the classical hallmarks of cancer. They are now in clinical trial and show potential for activity in...

Descripción completa

Detalles Bibliográficos
Autores principales: Beloueche-Babari, Mounia, Arunan, Vaitha, Jackson, L. Elizabeth, Perusinghe, Nina, Sharp, Swee Y., Workman, Paul, Leach, Martin O.
Formato: Texto
Lenguaje:English
Publicado: Impact Journals LLC 2010
Materias:
Research Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2965833/
https://www.ncbi.nlm.nih.gov/pubmed/21037799

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2965833/
https://www.ncbi.nlm.nih.gov/pubmed/21037799

Ejemplares similares